UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Renalase may be cleaved in blood. Are blood chymotrypsin-like enzymes involved?

Medical hypotheses, 2022-08, Vol.165, p.110895, Article 110895

2022

Volltextzugriff (PDF)

Ligand-receptor binding kinetics in drug design

Biomeditsinskaia khimiia, 2020-01, Vol.66 (1), p.42-53

2020

Volltextzugriff (PDF)

Ligand–Receptor Binding Kinetics in Drug Design

Biochemistry (Moscow). Supplement. Series B, Biomedical chemistry, 2020-07, Vol.14 (3), p.228-240

2020

Volltextzugriff (PDF)

The search for potential hypotensive peptides in the amino acid sequence of human renalase and their identification in proteolytic fragments of this protein

Biomeditsinskaia khimiia, 2023-12, Vol.69 (6), p.403-408

2023

Volltextzugriff (PDF)

The interactions of abiraterone and its pharmacologically active metabolite D4A with cytochrome P450 2C9 (CYP2C9)

Biomeditsinskaya Khimiya, 2022-06, Vol.68 (3), p.201-211

2022

Volltextzugriff (PDF)

A Way for Finding Ligands for New Binding Sites

Biomedical Chemistry: Research and Methods, 2023-10, Vol.6 (3), p.e00200

2023

Volltextzugriff (PDF)

Renalase, a new secretory enzyme responsible for selective degradation of catecholamines: Achievements and unsolved problems

Biochemistry (Moscow), 2010-08, Vol.75 (8), p.951-958

2010

Volltextzugriff (PDF)

Prediction of protein post-translational modifications: main trends and methods

Russian chemical reviews, 2014-01, Vol.83 (2), p.143-154

2014

Volltextzugriff (PDF)

The history of renalase from amine oxidase to alpha-NAD(P)H-oxidase/anomerase

Biomeditsinskaya Khimiya, 2015-11, Vol.61 (6), p.667-679

2015

Volltextzugriff (PDF)

New inhibitors of 5-lipoxygenase catalytic activity based on 2-(3-methylphenyl)propanoic acid and 4-substituted morpholine derivatives

Biochemistry (Moscow), 2014-04, Vol.79 (4), p.376-384

2014

Volltextzugriff (PDF)

Computer-aided design and discovery of protein-protein interaction inhibitors as agents for anti-HIV therapy

SAR and QSAR in environmental research, 2014-01, Vol.25 (6), p.457-471

2014

Volltextzugriff (PDF)

Computer modelling of monoaminoxidases

Biomeditsinskaia khimiia, 2015-03, Vol.61 (2), p.265-271

2015

Volltextzugriff (PDF)

Bacterial TEM-type serine beta-lactamases: structure and analysis of mutations

Biomeditsinskaya Khimiya, 2017-11, Vol.63 (6), p.499-507

2017

Volltextzugriff (PDF)

Prospects for the design of new therapeutically significant protease inhibitors based on knottins and sunflower seed trypsin inhibitor (SFTI 1)

Biomeditsinskaia khimiia, 2016-05, Vol.62 (4), p.353-368

2016

Volltextzugriff (PDF)

Modified Knottins as Potential Inhibitors of HCV NS3 Protease

Biomedical Chemistry: Research and Methods, 2024-08, Vol.7 (3), p.e00235

2024

Volltextzugriff (PDF)

The effect of isatin on protein-protein interactions between cytochrome b5 and cytochromes P450

Biomeditsinskaia khimiia, 2017-03, Vol.63 (2), p.170-175

2017

Volltextzugriff (PDF)

Interaction of novel oxazoline derivatives of 17(20)e-pregna-5,17(20)-diene with cytochrome P450 17A1

Biomeditsinskaia khimiia, 2016-01, Vol.62 (1), p.38-44

2016

Volltextzugriff (PDF)

Investigation the role of mutations M182T and Q39K in structure of beta-lactamase TEM-72 by molecular dynamics method

Biomeditsinskaia khimiia, 2016-07, Vol.62 (5), p.527-534

2016

Volltextzugriff (PDF)

Cytotoxic activity and molecular modeling of progestins - pregna-D'-pentarans

Biomeditsinskaia khimiia, 2016-03, Vol.62 (3), p.290-294

2016

Volltextzugriff (PDF)

Effect of Geldanamycin Binding on the Thr90 Phosphorylation Site of Hsp90

Biomedical Chemistry: Research and Methods, 2021-09, Vol.4 (3), p.e00145

2021

Volltextzugriff (PDF)

New Nitrogen-containing Androstane Derivatives Suppressing Prostate Carcinoma Cells Proliferation

Biomedical Chemistry: Research and Methods, 2024-08, Vol.7 (3), p.e00241

2024

Volltextzugriff (PDF)

Molecular modeling of interaction of 17(20) and 17(20) E-pregna-5,17(20)-dien-21-oyl amides with the nuclear receptor LXRb

Biomeditsinskaya Khimiya, 2013-05, Vol.59 (3), p.321-329

2013

Volltextzugriff (PDF)

Construction and Expression of the Chimeric Human Renalase Gene Encoding the N-Terminal Signal Sequence of the Secretory Protein Prolactin

Biomedical Chemistry: Research and Methods, 2022-06, Vol.5 (2), p.e00175

2022

Volltextzugriff (PDF)

Potential inhibitors of protease 3CLpro virus COVID-19: drug reposition

Biomedical Chemistry: Research and Methods, 2020-04, Vol.3 (1), p.e00124

2020

Volltextzugriff (PDF)

INTERACTIONS OF ANTICANCER DRUGS – ABIRATERONE AND GALETERONE – WITH CYTOCHROME P450 51A1 (CYP51A1)

BIOTECHNOLOGY: STATE OF THE ART AND PERSPECTIVES, 2021, Vol.1 (19), p.149-150

2021

Volltextzugriff (PDF)

1 – 25 von 51

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(37)
Mit Volltextzugriff
(19)

Publikationsform

Artikel
(50)
Tagungsberichte
(1)

Sprache

Englisch
(34)
Russisch
(17)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Renalase may be cleaved in blood. Are blood chymotrypsin-like enzymes involved?

Ligand-receptor binding kinetics in drug design

Ligand–Receptor Binding Kinetics in Drug Design

The search for potential hypotensive peptides in the amino acid sequence of human renalase and their identification in proteolytic fragments of this protein

The interactions of abiraterone and its pharmacologically active metabolite D4A with cytochrome P450 2C9 (CYP2C9)

A Way for Finding Ligands for New Binding Sites

Renalase, a new secretory enzyme responsible for selective degradation of catecholamines: Achievements and unsolved problems

Prediction of protein post-translational modifications: main trends and methods

The history of renalase from amine oxidase to alpha-NAD(P)H-oxidase/anomerase

New inhibitors of 5-lipoxygenase catalytic activity based on 2-(3-methylphenyl)propanoic acid and 4-substituted morpholine derivatives

Computer-aided design and discovery of protein-protein interaction inhibitors as agents for anti-HIV therapy

Computer modelling of monoaminoxidases

Bacterial TEM-type serine beta-lactamases: structure and analysis of mutations

Prospects for the design of new therapeutically significant protease inhibitors based on knottins and sunflower seed trypsin inhibitor (SFTI 1)

Modified Knottins as Potential Inhibitors of HCV NS3 Protease

The effect of isatin on protein-protein interactions between cytochrome b5 and cytochromes P450

Interaction of novel oxazoline derivatives of 17(20)e-pregna-5,17(20)-diene with cytochrome P450 17A1

Investigation the role of mutations M182T and Q39K in structure of beta-lactamase TEM-72 by molecular dynamics method

Cytotoxic activity and molecular modeling of progestins - pregna-D'-pentarans

Effect of Geldanamycin Binding on the Thr90 Phosphorylation Site of Hsp90

New Nitrogen-containing Androstane Derivatives Suppressing Prostate Carcinoma Cells Proliferation

Molecular modeling of interaction of 17(20) and 17(20) E-pregna-5,17(20)-dien-21-oyl amides with the nuclear receptor LXRb

Construction and Expression of the Chimeric Human Renalase Gene Encoding the N-Terminal Signal Sequence of the Secretory Protein Prolactin

Potential inhibitors of protease 3CLpro virus COVID-19: drug reposition

INTERACTIONS OF ANTICANCER DRUGS – ABIRATERONE AND GALETERONE – WITH CYTOCHROME P450 51A1 (CYP51A1)

Suchergebnisse filtern